O presente trabalho conclui que:
Foram identificadas todas as espécies do complexo C. parapsilosis no grupo amostral trabalhado, sendo que a prevalência de C. parapsilosis stricto sensu foi a mais expressiva;
A técnica de identificação com o gene SADH mostrou-se mais eficiente que a de marcadores microssatélites na identificação de espécies do complexo C. parapsilosis.
As espécies de C. parapsilosis apresentam comportamento diferente quanto às propriedades e fatores de virulência, demonstrando grande variação na virulência em isolados pertencentes a mesma espécie;
Isolados de C. parapsilosis provenientes de urina foram os que apresentaram maior quantidade de fatores de virulência e os isolados de secreção vaginal foram os que apresentaram formação de biofilme superior aos demais sítios;
Encontrou-se correlação positiva dos isolados entre as propriedades de virulência adesão e biofilme;
Não foi identificada associação entre espécie do complexo C. parapsilosis e o sítio anatômico colonizado, nem das espécies e as propriedades e fatores de virulência.
Referências
1. ABI-CHACRA, E. A.; SOUZA, L. O. P.; CRUZ, L. P.; BRAGA-SILVA, L. A.; GONÇALVES, D. S.; SODRÉ, C. L.; RIBEIRO, M. D.; SEABRA, S. H.; FIGUEIREDO-CARVALHO, M. H. G.; BARBEDO, L. S.; ZANCOPÉ-OLIVEIRA, R. M.; ZICCARDI, M.; SANTOS, A. L.S. Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex.
Federation of European Microbiological Societies, v. 13, 2013.
2. AOKI, S.; ITO-KUWA, S.; NAKAMURA, Y.; MASUHARA, T. Comparative pathogenicity of wild-type strains and respiratory mutants of Candida albicans in mice.
Zentralbl Bakteriol, p. 332-343, 1990.
3. ARRAM, S. B. I. Epidemiologia molecular de isolados de Candida spp. obtidos de pacientes pediátricos com candidemia. Dissertação de mestrado. Curitiba: Universidade Federal do Paraná, 2008. p. 58.
4. ATALAY, M. A.; KOC, A. N.; DEMIR, G.; SAV, H. Investigation of possible virulence factors in Candida strains isolated from blood cultures. Niger Journal Clinical
Practice, p. 52-55, 2015.
5. BACELO, K. L. Avaliação da variabilidade fenotípica e molecular de isolados de Candida albicans após período de armazenamento das culturas e em duas ocasiões de coleta. Dissertação de mestrado. Ribeirão Preto: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, 2008. p. 110.
6. BARBEDO, L. S.; SGARBI, D. B. G. Candidiasis. DST-Jornal Brasileiro de Doenças
Sexualmente Transmissíveis, v. 22, p. 22-38, 2010.
7. BASSETI, M.; RIGHI, E.; COSTA, A.; FASCER, R.; MOLINARI, M.P.; ROSSO, R.; PALLAVICINI, F. B.; VISCOLI, C. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infectious Diseases, v. 6, p. 21-27, 2006.
8. BERTINI, A.; BERNARDIS, F.D.; HENSGENS, L.A.M.; SANDINI, S.; SENESI, S.; TAVANTI, A. Comparison of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis adhesive properties and pathogenicity. Inetrnational Journal of
Medical Microbiology, v. 303, p. 98-103, Março 2013.
9. BIASOLI, M. S.; TOSELLO, M. E.; MAGARO, H. M. Adherence of Candida strains isolated from the human gastrointestinal tract. Mycoses, p. 465-469, 2002.
10.BRANCO, P. V. G. C.; ANJOS, D. C. V.; NASCIMENTO, F. B.; VALE, I. N. F.; AZEVEDO, C. M. A. S. P.; MONTEIRO, S. G.; FIGUEIREDO, P. M. S.; MONTEIRO, C. A. Prevalência e produção de exoenzimas por espécies de Candida provenientes da mucosa bucal de pacientes com AIDS e indivíduos hígidos. Revista de Patologia
Tropical, v. 41, p. 427-441, Outubro-Dezembro 2012.
11.BRILHANTE, R. S.; JESUS; S. R., SOUZA, C. M. C.; TEIXEIRA, C. E.; BRITO, M. R.; BANDEIRA, S. P. A. L.; MONTEIRO, A. J.; AGUIAR, C. R.; JESUS, P. G. B. T.; MOREIRA, J. L.; SIDRIM, J. J. Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex. Journal Medical of
Microbiology, Novembro 2014
12.CANTÓN, E.; PEMÁN, J.; QUINDÓS, G.; ERASO, E.; MIRANDA-ZAPICO, I.; ALVAREZ, M.; MERINO, P.; CAMPOS-HERRERO, I.; MARCO, F.; PEDROSA, E.G.G.; YAGÜE, G..; GUNA, R.; RUBIO, C.; MIRANDA, C.; PAZOS, C.; VELASCO, D. Prospective Multicenter Study of the Epidemiology, Molecular Identification and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis Isolated from Patients with Candidemia.
13.CHICKERING, G. Assaying virulence in 14 clinical isolates of Candida parapsilosis..
Dissertação de Mestrado. Faculty of Worcester Polytechnic Institute, 2013
CHIN, V. K.; FOONG, K.J.; MAHA, A.; RUSLIZA, B.; NORHAFIZAH, M.; NG, K. P.; CHONG, P. P. Candida albicans isolates from a Malaysian hospital exhibit more potente phospholipase ande haemolysin activities than non albicans Candida isolates.
Tropical Biomedicine, p. 654-662, 2013.
14.CHOW, B. D. W; LINDEN, J. R.; BLISS, J. M. Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting. Expert Review of
Anti- infective Therapy, Agosto 2012.
15.CLEVELAND, A. A.; HARRISON, L. H.; FARLEY, M. M.; HOLLICK, R.; STEIN, B.; CHILLER, T. M.; LOCKHART,S. R.; PARK, B. J. Declining Incidence of Candidemia and the Shifiting Epidemiology of Candida Resistance in two U.R. Metropolitan Areas, 2008-2013: results form population- based surveillance. PLoS ONE, 2015
16.COLOMBO, A.; GUIMARÃES, T. Epidemiologia das infecções hematogênicas por Candida spp. Revista da Sociedade Brasileira de Medicina Tropical, v. 36, p. 599-607, 2003.
17.D’EÇA, J. A.; SILVA, A. F.; ROSA, F. C.; MONTEIRO, S. G.; FIGUEIREDO, P. M. S.; ANDRADE-MONTEIRO, C. In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida. Revista da Sociedade Brasileira de
Medicina Tropical, v. 44, p. 334-338, 2011.
18.DE LUCA, C.; GUGLIELMINETTI, M.; FERRARIO, A.; CALABRO, M.; CASARI, E. Candidemia:species involved, virulence factors and antimycotic susceptibility. New
Microbiologica, v. 35, p. 459-468, Abril 2012.
19.DE PAULA, S. B.; BARTELLI, T.F.; Di RAIMO, V.; SANTOS, J.P.; MOREY, A.T.; BOSINI, M.A.; NAKAMURA, C.V.; YAMAUCHI, L.M.; YAMADA-OGATTA, S.F. Effect of Eugenol on Cell Surface Hydrophobicity, Adhesion, and Biofilm of Candida tropicalis and Candida dubliniensis Isolated from Oral Cavity of HIV-Infected Patients.
Evidence-Based Complementary and Alternative Medicine, 2014.
20.DING, C.; VIDANES, G. M.; MAGUIRE, S. L.; GUIDA, A.; SYNNOTT, J. M.; ANDES, D. R.; BUTLER, G. Conserved and divergent roles of Bcr1 and CFEM proteins in Candida parapsilosis and Candida albicans. PLoS One, v. 6, 2011.
21.DUARTE, T. R. Increased expression of keratinase and other peptidases by Candida parapsilosis mutants. Dissertação de mestrado, Ribeirão Preto, v. 44, Março 2011. 22.FAVERO, D. Hemolytic factor production by clinical isolates of Candida species. New
York, 2013.
23.FENG, X.; WU, Z.; LING, B.; PAN, S.; LIAO, W.; PAN, W.; YAO, Z.. Identification and differentiation of Candida parapsilosis complex species by use of exon-primed intron-crossing PCR. Journal of Clinical Microbiology , v. 52, p. 1758-1761, Maio 2014.
24.FERRO, T. A. F.; MORAES, F. C.; SILVA, A. M.; PORCY, C.; SOARES, L. A.; MONTEIRO, C. A.; LOBÃO, N. T. M.; MELLO, F. A. A.; NETO, V. M.; FIGUEIREDO, P. M. S. Characterizattion of Virulence factors in Enteroaggregative and atypical enteropathogenic Escherichia coli strains isolated from children with diarrhea. Advances in Infectious Diseases, 2012.
25.FRANÇOIS, L. M.; DUNCAN, W.; BERNHARD, H. Candida albicans pathogenicity mechanisms. Virulence , v. 4, 2013.
26.GÁCSER, A.; SCHÄFER, W.; NOSANCHUK, J.S.; SALOMON, S.; NOSANCHUK, J.D. Virulence of Candida parapsilosis, Candida orthopsilosis and C. metapsilosis in reconstituted human tissue models. Fungal Genetics and Biology, v. 44, p. 1336-1341, 2007.
27.GE, Y. P.; LU, G.X.; SHEN, Y.N.; LIU, W.D. In vitro evaluation of phospholipase, proteinase, and esterase activities of Candida parapsilosis and Candida metapsilosis.
Mycopathologia, 2011.
28.GEBREMEDHIN, S.; DOROCKA-BOBKOWSKA, B.; PRYLINSKI, M.; KONOPRA, K.; DUZGUNES, N. Miconazole activity against Candida biofilms developed on acrylic discs. Journal of Physiology and Pharmacology, p. 593-600, 2014.
29.GERMAIN, G.; LAVERDIEREM, M.; PELLETIER, R.; BOURGAULT, A.M.; LIBMAN, M.; LEMIEUX, C.; NOEL, G. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites:results of a 2 year(1996 to 1998) Multicenter Surveillance study in Quebec, Canada. Journal of Clinical
Microbiology, v. 39, p. 949-953, 2001.
30.GONÇALVES, S. S.; AMORIM, C.S.; NUCCI, M.; PADOVAN, A.C.; BRIONES, M.R.; MELO, A.S.; COLOMBO, A.L. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clinical Microbiology Infectious., Julho 2010. 31.GUPTA, A.; GUPTA, A.; VARMA, A. Candida glabrata candidemia: An emerging
threat in critically ill patients. Indian Journal of Critical Care Medicine, Março, 2015. 32.HAYS, C.; DUHAMEL, C.; CATTOIR, V.; BONHOMME, J. Rapid and accurate
identification of species belonging to the Candida parapsilosis complex by real time PCR and melting curve analysis. Journal of Medical Microbiology, v. 60, p. 477-480, 2011.
33.HOLLAND, L. M.; SCHRÖDER, M. S.; TURNER, S. A.; TAFF, D. A.; GRÓZER, Z.; GÁCSER, A.; AMES, L.; HAYNES, K.; HIGGINS, D. G.; BUTLER, G. Comparative Phenotypic Analysis of the Major Fungal Pathogens Candida parapsilosis and Candida albicans. PLos Pathogen, Setembro 2014.
34.ISSA, S. Y.; BADRAN, E. F.; AKL, K. F.; SHEHABI, A. A.. Epidemiological characteristics of Candida species colonizing oral and rectal sites of Jordanian infants.
BMC Pediatric, 2011.
35.KING, R. D.; LEE, J. C.; MORRIS, A. L. Adherence of Candida albicans and other Candida species to mucosal epithelial cells. Infectious Immunogical, v. 27, p. 667-674, 1980.
36.KLOTZ, S. A.; LIPKE, P. N. The perfect adhesive. Current research, technology and
education topic in Applied Microbiology and Microbial Biotechnology, v. 16, p.
838-844, 2010.
37.KURTZMAN, P. F. J. The yeasts: a taxonomic study.. Amsterdam: Elsevier, p. 1055, 1998.
38.LASKER, B. A.; BUTLER, G.; LOTT, T. J. Molecular genotyping of Candida parapsilosis group I clinical isolates by analysis of polymorphic microsatellite markers.
Journal of Clinical Microbiology, v. 44, p. 750-759, 2006.
39.LINARES, C. E. B.; GRIEBELER, D.; CARGNELUTTI, D.; ALVES, S.H.; MORSCH, V. M.; SCHETINGER, M. R. C.. Catalase activity in Candida albicans exposed to antineoplastic drugs. Journal of medical microbiology, v. 55, p. 259-262, Março 2006.
40.LUO, G.; SAMARANAYAKE, L. P.; YAU, J. Y. Y. Candida Species Exhibit Differential In Vitro Hemolytic Activities. Journal of Clinical Microbiology, v. 39, n. 8, p. 2971-2974, Agosto 2001.
41.MADHAVAN, P. JAMAL, F.; CHONG, P.P.; NG, K.P. Identification of local clinical Candida isolates using CHROMagar Candida TM as a primary identification method for various Candida species. Tropical Biomedicine, v. 28, p. 269-274, 2011.
42.MALCOK, H. K.; AKTAS, E.; AYYILDIZ, A.; YIGIT, N.; YAZGI, H.. Hemolytic Activities of the Candida Species in Liquid Medium. The Eurasian Journal of
Medicine, p. 95-98, 2009.
43.MATTEI, A. S.; ALVES, S. H.; SEVERO, C. B.; GUAZZELLI, L. S.; OLIVEIRA, F. M.; SEVERO, L.C. Determination of germ tube, phospholipase, and proteinase production by bloodstream isolates of Candida albicans. Revista Sociedade Brasileira
Medicina Tropical, Uberaba, v. 46, Junho 2013.
44.MENEZES, V. M.; VALE, I. N. F.; MONTEIRO, S. G.; GONÇALVES, L. H. B.; FIGUEIREDO, P. M. S.; MONTEIRO, C. A. Classificação da capacidade de adesão de isolados clínicos de Candida spp. em padrões de arranjos celulares distintos. Revista
de Patologia Tropical, v. 42, p. 289-300, 2013.
45.MIRHENDI, H.; BRUUN, B.; SCHONHEYDER, H. C.; CHRISTENSEN, J. J.; FUURSTED, K.; GAHRN-HANSEN, B.; JOHANSEN, H. K.; NIELSEN, L.; KNUDSEN, J. D.; ARENDRUP, M. C. Molecular screening for Candida orthopsilosis and C. metapsilosis among Danish Candida parapsilosis group blood culture isolates: proposal of a new RFLP profile for differentiation. Journal of Medical Microbiology, v. 59, p. 414-420, Abril 2010.
46.MIYASAKA, N. R. S.; UNTERKIRCHER, C. S.; SHIMIZU, M. T. Catalase activity of different Candida species after exposition to specific antiserum. Brazilian Journal
of Microbiology, p. 35-39, 2008.
47.MOTA, A. J. Genotipagem por sequenciamento e PCR-RFLP do DNA ribossomal e verificação da metodologia de identificação de possíveis fatores de virulência em sete espécies do gênero Candida. In: ______ Dissertação de Mestrado. São José dos Campos: Universidade do Vale do Paraíba, 2007. p. 142.
48.NAKAGAWA, Y. Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells. Microbiology and Immunology, v. 52, p. 16-24, Março 2008.
49.OLIVEIRA, S. K. R.; ANJOS, D. C. V.; GONÇALVES, L. H. B.; FERRO, T. A. F.; MONTEIRO, S. GOMES; FIGUEIREDO, P. M. S.; MONTEIRO, C. A.. Prevalence and production of enzymes by Candida isolates from vaginal secretion samples. Revista
de Patologia Tropical, p. 161-176, 2013.
50.PAKSHIR, Z.; ZOMORODIAN, K.; KARAMITALAB, M.; JAFARI, M.; TARAZ, H.; EBRAHIMI; H.. Phospholipase, esterase and hemolytic activities of Candida spp. isolated from onychomycosis and oral lichen planus lesions. Journal Mycology
Medical, Junho 2013.
51.PAMMI, M.; HOLLAND, L.; BUTLER, G.; GACSER, A.; BLISS, J.M. Candida parapsilosis is a Significant Neonatal Pathogen: A systematic review and meta-analysis.
Pediatric Infectious Diseases Journal, p. 206-216, Maio 2013.
52.PANNANUSORN, S.; RAMIREZ-ZAVALA, B.; LÜNSDORF, H.; AGERBERTH, B.; MORSCHHÄUSER, J.; RÖMLING, U. Characterization of Biofilm Formation and the Role of BCR1 in Clinical Isolates of Candida parapsilosis. Eukaryotic Cell, v. 13, p. 438-451, Abril 2014.
53.PFALLER, M. A.; JONES, R.N.; DOERN, G.V.; SADER, H. S.; MESSER, S. A.; HOUSTON, A.; COFFMAN, S.; HOLLIS, R. J. Bloodstream infections due to Candida species: SENTRY Antimicrobial Surveillance Program in North America and Latim America,1997-1998. Antimicrobial Agents and Chemotherapy, v. 44, p. 747-751, 2000.
54.PRICE, M. F.; WILKINSON, I. D.; GENTRY, L. O. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia, v. 20, p. 7-14, 1982.
55.PRYSZCZ, L. P.; NÉMETH, T.; GÁCSER, A.; GABALDÓN, T. Genome Comparison of Candida orthopsilosis Clinical strains reveals the existence of hybrids between two distinct subspecies. Genome Biology and Evolution, p. 1069-1078, Abril 2014. 56.RAEDER, U.; BRODA, P. Rapid preparation of DNA from flamentous fungi. Letters
in Applied Microbiology, v. 1, p. 17-20, 1985.
57.RAMESH, N.; PRIYADHARSINI, M.; SUMATHI, C.S.; BALASUBRAMANIAN, V.; HEMAPRIYA, J.; KANNAN, R. Virulence Factors and Anti Fungal Sensitivity Pattern of Candida Sp. Isolated from HIV and TB Patients. Indian Journal
Microbiology, p. 273-278, Julho 2011.
58.REILLY, A. A.; SALKIN, I. F.; MCGINNIS, M. R. Evaluation of mycology laboratory proficiency testing. Journal Clinical of Microbiology, v. 37, p. 2297-2305, 1999. 59.RICETO, E. B.; MENEZES, R.P.; PENATTI, M.P.; PEDROSO, R. D. Enzymatic and
hemolytic activity in different Candida species. Revista Iberoamericana de
Micologia, Abril 2014.
60.ROMEO, O.; DELFINO, D.; COSTANZO, B.; CASCIO, A.; CRISEO, G. Molecular characterization of Italian Candida parapsilosis isolates reveals the cryptic presence of the newly described species Candida orthopsilosis in blood cultures from newborns.
Diagnostic Microbiology and Infectious Disease, p. 234-238, 2012.
61.ROSSONI, R. D.; BARBOSA, J.D.; VILELA, S.F.; JORGE, A.O.C.; JUNQUEIRA, J.C. Comparison of the hemolytic activity between C. albicans and non-albicans Candida species. Brazilian Oral Research, São Paulo, v. 27, Novembro 2013.
62.ROWEN, J. L.; TATE, J. M.; NORDOFF, N. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. Journal of
Clinical Microbiology, v. 37, p. 3735-3737, 1999.
63.SABINO, R.; SAMPAIO, P.; ROSADO, L.; STEVENS, D.A.; CLEMONS, K.V.; PAIS, C. New polymorphic microsatellite markers able to distinguish among Candida parapsilosis sensu stricto Isolates. Journal of Clinical Microbiology, v. 48, p. 1677-1682, 2010.
64.SABINO, R.; SAMPAIO, P.; CARNEIRO, C.; ROSADO, L.; PAIS, C. Isolates from hospital environments are the most. BMC Microbiology, 2011.
65.SAMBROOK, J.; FRSTCH, E. F.; MANIATIS, T. Molecular Cloning: a Laboratory Manual. New York: Cold Spring Harbor, 2002.
66.SAMPAIO, P.; GUSMÃO, L.; ALVES, C.; VAZ-PINA, C.; AMORIM, A.; PAIS, C.A. Highly polymorphic microsatellite for the identification of Candida albicans strains.
Journal of Clinical Microbiology, v. 41, p. 552-557, 2003.
67.SAMPAIO, P.; GUSMÃO, L.; CORREIA, A.; ALVES, C.; RODRIGUES, A.G.; PINA-VAZ, C.; AMORIM, A.; PAIS, C. New microsatellite multiplex PCR for Candida parapsilosis strain typing reveals microevolutionary changes. Journal of
68.SCHULMAN, J., STRICOF, R.; STEVENS, T. P.; HORGAN, M.; GASE, K.; HOLZMAN, I.R., KOPPEL,R. I.; NAFDAY, S.; GIBBS, K.; ANGERT, R.; SIMMON, D.S.A.; FURDON,S.A.; SAIMAN, L. Statewide NICU Central-Line-Associated Bloodstream Infection Rates Decline After Bundles and Checklists. Pediatrics. Março, 2011.
69. SHARMA, M.; BISWAS, D.; KOTWAL, A.; THAKURIA, B.; KAKATI, B.; CHAUHAN,B.S.; PATRAS, A. Ibuprofen-Mediated Reversal of Fluconazole Resistance in Clinical Isolates of Candida. Journal of Clinical e Diagnostic Research, Janeiro, 2015
70.SHIN, J. H.; KEE, S.J.; SHIN, M.G.; KIM, S.H; SHIN, D.H.; LEE, S.K.; SUH, S.P.; RYANG, D.W. Biofilm production by isolates of Candida Species recovered from nonneutropenic patients:comparison of bloodstream isolates with isolates from other sources. Journal of clinical microbiology, v. 40, p. 1244-1248, 2002.
71. SHIVAPRAKASHA, S.; RADHAKRISHNAN, K.; KARIM, P.M. Candida spp., other than Candida albicans: a major cause of fungaemia in a tertiary care centre. Indian
Journal Medical Microbiology. 2007.
72.SILVA, S.; NEGRI, M.; HENRIQUES, M.; OLIVEIRA, R.; WILLIAMS, D.; AZEREDO, J. Silicone colonization by non-Candida albicans Candida species in the presence of urine. Journal Medical Microbiology, v. 59, p. 747-754, Julho 2010. 73.SILVA, S.; NEGRI, M.; HENRIQUES, M.; OLIVEIRA, R.; WILLIAMS, D.W.;
AZEREDO, J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiology
Reviews, p. 288-305, Junho 2011.
74.SKINNER, C. E.; FLETCHER, D. W. A review of the genus Candida. Bacteriol Rev., v. 24, p. 397-466, 1958.
75.SOUSA, I. C. D. Descrição e caracterização de um locus de microssatélite no gene IFF8 de Candida albicans. In: AVEIRO, U. D. Dissertação de Mestrado. Aveiro: [s.n.], 2007.
76.SPECIAN, A. F. L.; FURLANETO-MAIA, L.; ANDRADE, C. G. T. J.; FURLANET, M. C. Ultrastructural Analysis of in Vitro Adherence and Production of Acid Proteases by Clinical Isolates of Candida parapsilosis Sensu Stricto Following Growth in the Presence of Keratinous Substrates from Human Source. Advances in Microbiology, Dezembro 2013.
77.TAMURA, N. K.; NEGRI, M.F.N.; BONASSOLIL, L.A.; SVIDZINSKI, T.I.E.. Virulence factors for Candida spp. recovered from intravascular catheters and hospital worker's hands. Revista da Sociedade Brasileira de Medicina Tropical, v. 40, n. 1, p. 91-93, Jan-Fev 2007.
78.TAVANTI, A.; DAVIDSON, A.D.; GOW, N.A.R.; MAIDEN, M.C.J.; ODDS, F.C.. Candida orthopsilosis and Candida metapsilosis spp. to replace Candida parapsilosis Group II and III. Journal of Clinical Microbiology, v. 43, p. 284-292, 2005.
79.TAVANTI, A.; HENSGENS, L.A..M.; GHELARDI, E.; CAMPA, M.; SENESI, S.. Genotyping of Candida orthopsilosis Clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. Journal of Clinical Microbiology , v. 45, p. 1455-1462, 2007.
80.TAVANTI, A.; HENSGENS, L.A.M.; MOGAVERO, S.; MAJOROS, L.; SENESI, S.; CAMPA, M. Genotypic and phenotypic properties of Candida parapsilosis sensu stricto strains isolated from different geografic regions and body sites. BMC
81.TRABASSO, P.; MATSUZAWA, T.; FAGNANI, R.; MURAOSA, Y.; TOMINAGA, K.; RESENDE, M. R.; KAMEI, K.; MIKAMI, Y.; SCHREIBER, A. Z.; MORETTI, M. L.Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species. Mycopathologia, Fevereiro 2015 82.TRABULSI L.R, A. F. Microbiologia. São Paulo: Atheneu, 2005.
83.TREVINO-RANGEL, R. J.; RODRIGUEZ-SANCHEZ, I. P.; ROSAS-TARACOC, A.G.; HERNANDEZ-BELLO, R.; GONZALEZ, J.G.; GONZALEZ, G. M. Biofilm formation and genetic variability of BCR1 gene in the Candida parapsilosis complex.
Revista Iberoamericana, 2015.
84.TREVIÑO-RANGEL, R. J.; GONZÁLEZ, J. G.; GONZÁLEZ, G. M. Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex. Medical Mycology, v. 51, Abril 2013.
85.TROFA, D.; GÁCSER, A.; NOSANCHUK, J. D. Candida parapsilosis, an Emerging Fungal Pathogen. Clinical Microbiology Reviews, v. 21, p. 606-625, Outubro 2008. 86.WENZEL, R. P.; EDMOND, M. B. The impact of Hospital Acquired Bloodstream
infections. Emerging Infectious Diseases, v. 7, p. 174-177, 2001.
87.WISPLINGHOFF, H.; BISCHOFF, T.; TALLENT, S.M.; SEIFERT, H.; WENZEL, R.P.; EDMOND, M.B. Nosocomial bloodstream infections in US hospitals: Analysis of 24.179 cases from a prospective nationwide surveillance study. Clinical Infectious
Diseases, 2004.
88.WISE, M. G.; HEALY, M.; REECE, K.; SMITH, R.; WALTON, D.; WENDY, D.; RENWICK, A.; HOUNG, J.; YOUNG, S.; TARRAND, J.; KONTOYIANNIS, D.P.. Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence based PCR. Journal of Medical
Microbiology, v. 56, p. 778-787, 2007.
89.WYSONG, D. R.; CHRISTIN, L.; SUGAR, A.M.; ROBBINS, P.W.; DIAMOND, R.D. Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene. Infectious Immunological, 1998.
90.XU, J.; MILLAR, B.C.; MOORE, J.E.; MCCLURG, R.; WALKER, M.S.; EVANS, J.; HEDDERWICK, S.; MCMULLAN, R.. Comparison of APIC 20C with molecular identification of Candida spp. isolated from bloodstream infections. Journal Clinical
Pathology, v. 55, p. 774-777, 2002.
91.ZHAI, I. H. L.; XIE, L. X.; DONG, X. G. The roles of gelatinases in pathological changes of fungal keratitis in experimental rabbits. Chinese Journal of
Ophthalmology, p. 817-822, Setembro 2007.
92.ZHU, Y.; SHAN, Y.; FAN, S.; LI, J.; LIU, X. Candida parapsilosis Sensu Stricto and the Closely Related Species Candida orthopsilosis and Candida metapsilosis in Vulvovaginal Candidiasis. Mycopathologia, Fevereiro 2015.
ANEXO A- Parecer do comitê de ética e pesquisa da Universidade CEUMA
Projeto: Isolamento, identificação, estudo dos fatores de virulência e sensibilidade a antifúngico de isolados clínicos de Candida provenientes da flora vaginal de pacientes atendidas no Hospital da Mulher- Anjo da Guarda
ANEXO B- Protocolos de submissão do artigo “Prevalência de Candida spp. em amostras de secreção vaginal e sua relação com fatores associados à vulvovaginite”